Results 111 to 120 of about 6,753 (222)
Editorial: Stem cell research and therapy for liver and kidney diseases. [PDF]
Lv D, Li T.
europepmc +1 more source
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histologic features and treatment response.
Andrea Fava +48 more
wiley +1 more source
Bleomycin sclerotherapy for venous vascular malformations of the tongue. [PDF]
Agid N +4 more
europepmc +1 more source
Percutaneous Sclerotherapy of Postoperative Lymphoceles: A Systematic Review and Meta-analysis of Different Sclerosant Agents. [PDF]
Lippi M +9 more
europepmc +1 more source
A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease
ABSTRACT IgA nephropathy (IgAN) is the most frequently reported glomerular disease associated with inflammatory bowel disease (IBD), particularly Crohn's disease (CD), although pediatric cases remain rare. We report IgAN in a 16‐year‐old male with CD following intestinal surgery and during long‐term infliximab therapy, with renal impairment occurring ...
Giovanna Fernanda Vazzana +6 more
wiley +1 more source
A novel immunohistochemical staining method of frozen sections improves the intraoperative diagnosis of Sclerosing Pneumocytoma and bronchiolar adenoma. [PDF]
Liu Q, Luo J, Liang Q.
europepmc +1 more source
We performed endoscopic puncture and subsequent sclerotherapy for the laryngopharyngeal venous malformation. ABSTRACT Giant cervico‐laryngopharyngeal venous malformations are rare vascular anomalies that can cause life‐threatening airway obstruction, posing significant challenges in clinical management.
Hiromu Nakamura +6 more
wiley +1 more source
Chronic pruritus of unknown origin: assessment and management in general practice. [PDF]
Papas C, Muir J, Chan L.
europepmc +1 more source

